Diabetes Research and Clinical Practice
Volume 61, Issue 2 , Pages 143-144 , August 2003

The role of C-reactive protein in type 2 diabetes and its macrovascular complications in Chinese

References 

  1. Maseri A. Inflammation, arteriosclerosis, and ischemic events-exploring the hidden side of the moon. New Engl. J. Med. 1997;336:1014–1016
  2. Stern MP. Diabetes and cardiovascular disease: the “common soil” hypothesis. Diabetes. 1995;44:369–374
  3. Haidari M, Javadi E, Sadeghi B, Hajilooi-Ghanbili J. Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease. Clin. Biochem. 2001;33:309–315
  4. Verma S, Li SH, Badiwada MV, Weisel RD, Fedak PW, Li RK, et al. Endothelia antagonism and interleukin-6 inhibition attenuate the proathelogenic effects of C-reactive protein. Circulation. 2002;105:1890–1896
  5. Dandona P, Aliada A. A rational approach to pathogenesis and treatment of type 2 diabetes mellitus, insulin resistance, inflammation, and atherosclerosis. Am. J. Cardiol. 2002;90:27G–33G

PII: S0168-8227(03)00083-4

doi: 10.1016/S0168-8227(03)00083-4

Diabetes Research and Clinical Practice
Volume 61, Issue 2 , Pages 143-144 , August 2003

Article Tools